Trump OKs sale of revamped short-term health care plans

The Trump administration issued a final ruling on Wednesday allowing insurers to sell short-term, limited-duration health plans on the insurance markets as soon as this year.

GSK buys out Novartis in $13 billion consumer healthcare shake-up

GlaxoSmithKline (GSK.L) is buying Novartis (NOVN.S) out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches.

These Are the Trends to Watch, According to Goldman

From meatless meats to digital twins, the latest “emerging trends” identified by Goldman Sachs Group Inc. include technologies and investing strategies that have been around for a while. “What happens when everything old becomes new again?” the bank asked Wednesday in the second edition of its “Outsiders” series, meant to help investors “separate the hype from reality.”

Cold chain pharma logistics is heating up

Most of us have seen the ads, while millions are ordering fresh food delivered as ready-to-prepare ingredients to their homes-products that require control of exposure to extreme temperatures and extended last-mile transit times. This consumer-focused “cold chain”-temperature controlled supply chain-is only a recent example of a decades-long push to perfect a global system of item-level tracking in supply chain management.

Fallout from Hanjin’s bankruptcy has potential to impact ocean rates and capacity in the short-term

With Korean ocean carrier Hanjin Shipping, the seventh largest ocean liner in the world that handles roughly 7% of U.S.-Asia cargo, filing for bankruptcy earlier this week, what happens next in regards to what happens to the cargo that was moving on Hanjin vessels at that time, as well as its subsequent short-term impact on the global supply chain remains far from clear.